Cart
sales@molnova.com
FGFR4-IN-1
CAS No. 1708971-72-5
FGFR4-IN-1( —— )
Catalog No. M23769 CAS No. 1708971-72-5
FGFR4-IN-1 is a potent FGFR4 inhibitor (IC50: 0.7 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 57 | In Stock |
|
| 5MG | 87 | In Stock |
|
| 10MG | 170 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFGFR4-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionFGFR4-IN-1 is a potent FGFR4 inhibitor (IC50: 0.7 nM).
-
DescriptionFGFR4-IN-1 is a potent FGFR4 inhibitor (IC50: 0.7 nM).
-
In VitroFGFR4-IN-1 significantly inhibits the proliferation of HuH-7 hepatocellular carcinoma cells with IC50 of 7.8 nM.
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetFGFR
-
RecptorFGFR4
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1708971-72-5
-
Formula Weight493.52
-
Molecular FormulaC24H27N7O5
-
Purity>98% (HPLC)
-
SolubilityDMSO:6 mg/mL (12.16 mM; Need warming)
-
SMILESCOCCNc1cc(NC(N2c3nc(C=O)c(CN(CCOC4)C4=O)cc3CCC2)=O)ncc1C#N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ring-fused bicyclic pyridyl derivatives as fgfr4 inhibitors. WO 2015059668 A1
molnova catalog
related products
-
Rogaratinib
Rogaratinib is an aberrant inhibitor of fibroblast growth factor receptor (FGFR). Rogaratinib is as an orally available, selective and potent inhibitor of FGFR-1, -2 and -3 kinase activity.
-
Alofanib
Alofanib is a selective allosteric inhibitor of FGFR2 and has a dramatic inhibitory effect on FGF2-induced phosphorylation of FRS2a in KATO III cells (IC50 <10 nM).
-
Vofatamab
Vofatamab (B-701) is a fully human monoclonal antibody targeting FGFR3. Vofatamab has potential anticancer and antitumor activity and is often used in combination with other compounds to treat cancer.
